Seminars in Arthritis and Rheumatism
Volume 26, Issue 5 , Pages 740-754, April 1997

Clinical and subclinical alveolitis in connective tissue diseases assessed by bronchoalveolar lavage

    MD
  • Paolo Manganelli (Associate Professor)

      Affiliations

    • II Divisione Medica e Reumatologia, AziendaOspedaliera di Parma, Italy
  • , MD
  • Fausto Salaffi (Associate Professor)

      Affiliations

    • Clinica Reumatologica e Cattedra diReumatologia, Università di Ancona, Italy
    • Corresponding Author InformationAddress reprint requests to Fausto Salaffi, MD, Clinica Reumatologica, Università di Ancona, Ospedale A. Murri, Via dei Colli, 52, 60035-Jesi (Ancona)-Italy.
  • , MD
  • Alberto Pesci (Associate Professor)

      Affiliations

    • Instituto di Clinica delle Malattiedelle'Apparato Respiratorio, Università di Parma, Italy

Abstract 

Subclinical alveolitis, as assessed by bronchoalveolar lavage (BAL) cell analysis,may be present in the lower respiratory tract of a high proportion of symptom-less patients with connective tissue diseases (CTDs) with normal chest roentgenograms. The distribution of BAL cell types, mainly macrophages, lymphocytes, and polymorphonuclear neutrophils, varies according to type of CTD and to the presence of associated interstitial lung disease (ILD). Neverthe-less, subclinical alveolitis can be classified into two major groups: lymphocyte and neutrophil alveolitis. A mixed, lymphocyte and neutrophil alveolitis may be detected as well. Subclinical alveolitis, particularly in systemic sclerosis, frequently is associated with abnormalities of lung parenchyma as assessed by computed tomography (CT) scan, supporting the hypothesis that it may be associated with the development of overt ILD. Close follow-up of these patients is needed to better determine whether subclinical alveolitis precedes ILD and whether early detection of subclinical alveolitis in CTDs may identify those patients who are at risk for the development of ILD in the future.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0049-0172(97)80042-X

Seminars in Arthritis and Rheumatism
Volume 26, Issue 5 , Pages 740-754, April 1997